Acute renal failure related to intravenous immunoglobulin infusion in an elderly woman

Hong Kong Medical Journal

Volumn 11, Issue 1, 2005, Pages 45-49

  Kwan, T H ^a   Tong, M K H ^a   Siu, Y P ^a   Leung, K T ^a   Lee, H K ^a   Yung, C Y ^a   Au, T C ^a  

^a TUEN MUN HOSPITAL   (Hong Kong)

Author keywords

Immunoglobulins, intravenous; Kidney failure, acute; Maltose; Sucrose

Indexed keywords

ALPHA GLUCOSIDASE; ANTIBIOTIC AGENT; CREATININE; GLICLAZIDE; IMMUNOGLOBULIN; INTRAGAM P; LISINOPRIL; MALTOSE; METFORMIN; METOPROLOL; NIFEDIPINE; PREDNISOLONE; SUCRASE; SUCROSE;

ACUTE KIDNEY FAILURE; AGE; AGED; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BRUSH BORDER; CASE REPORT; CREATININE BLOOD LEVEL; DIABETES MELLITUS; ECHOGRAPHY; FEMALE; HEMOFILTRATION; HUMAN; HYPERTENSION; HYPOVOLEMIA; KIDNEY PROXIMAL TUBULE; NEPHROSIS; NEPHROTOXICITY; RISK FACTOR; SEPSIS; URINE VOLUME;

AGED; ANEMIA, HEMOLYTIC, AUTOIMMUNE; CREATININE; DIABETES MELLITUS; FEMALE; HEMOFILTRATION; HUMANS; HYPERTENSION; IMMUNOGLOBULINS, INTRAVENOUS; KIDNEY FAILURE, ACUTE; RECOVERY OF FUNCTION;

EID: 13844284202     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Knezevic-Maramica I, Kruskall MS. Intravenous immune globulins: an update for clinicians. Transfusion 2003;43: 1460-80.
2. Ahsan N, Wiegand LA, Abendroth CS, Manning EC. Acute renal failure following immunoglobulin therapy. Am J Nephrol 1996;16:532-6.
3. Monserrat AJ, Gotelli C, Garay R. Sequential histochemical features in experimental osmotic nephrosis. Virchows Arch B Cell Pathol 1969;3:365-76.
4. Costa V, Giuliani B. Electron microscopic observations on experimental osmotic nephrosis. Pathologica 1968;60:3-10.
5. Perazella MA, Cayco AV. Acute renal failure and intravenous immune globulin: sucrose nephropathy in disguise? Am J Ther 1998;5:399-403.
6. Hansen-Schmidt S, Silomon J, Keller F. Osmotic nephrosis due to high-dose immunoglobulin therapy containing sucrose (but not with glycine) in a patient with immunoglobulin A nephritis. Am J Kidney Dis 1996;28:451-3.
7. Ahsan N, Palmer BF, Wheeler D, Greenlee RG Jr, Toto RD. Intravenous immunoglobulin-induced osmotic nephrosis. Arch Intern Med 1994;154:1985-7.
8. Stewart RR, Winney RJ, Cash JD. Renal toxicity of intravenous immunoglobulin. Vox Sang 1993;65:244.
9. Haskin JA, Warner DJ, Blank DU. Acute renal failure after large doses of intravenous immune globulin. Ann Pharmacother 1999;33:800-3.
10. Silbernagl S. The role of brush border enzymes in tubular reabsorption of disaccharides; a microperfusion study in rat kidney. Pflugers Arch 1977;371:141-5.
11. Williams MA, Rhoades CJ, Provan D, Newland AC. In vitro cytotoxic effects of stabilizing sugars within human intravenous immunoglobulin preparations against the human macrophage THP-1 cell-line. Hematology 2003;8: 285-94.
12. Renal insufficiency and failure associated with immune globulin intravenous therapy-United States, 1985-1998. MMWR Morb Mortal Wkly Rep 1999;48:518-21.
13. Ballow M, Berger M, Bonilla FA, et al. Pharmacokinetics and tolerability of a new intravenous immunoglobulin preparation, IGIV-C, 10% (Gamunex, 10%). Vox Sang 2003; 84:202-10.
14. Ameratunga R, Sinclair J, Kolbe J. Increased risk of adverse events when changing intravenous immunoglobulin preparations. Clin Exp Immunol 2004;136:111-3.
15. Chun NS, Savani B, Seder RH, Taplin ME. Acute renal failure after intravenous anti-D immune globulin in an adult with immune thrombocytopenic purpura. Am J Hematol 2003;74:276-9.